Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects (Q39809887)

14 September 2017

title

Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects (English)

1 reference

Charlotte Cunningham-Rundles

14 September 2017

1 reference

6

object named as

Charlotte Cunningham-Rundles

1 reference

14 September 2017

Ami Mehra

1

1 reference

14 September 2017

Peter Sidi

2

1 reference

14 September 2017

John Doucette

3

1 reference

14 September 2017

Lissette Estrella

4

1 reference

14 September 2017

Helen Rouvelas

5

1 reference

14 September 2017

publication date

1 August 2007

1 reference

Annals of Allergy, Asthma & Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

99

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

143-150

1 reference

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Primary immunodeficiency diseases: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

The primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Primary immunodeficiency diseases in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Common variable immunodeficiency: clinical and immunological features of 248 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Chronic granulomatous disease. Report on a national registry of 368 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

X-Linked Agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Quality of US outpatient care: temporal changes and racial/ethnic disparities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Recognizing primary immune deficiency in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Chronic and recurrent pneumonias in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Comparing a diagnosis list with a survey method to identify children with chronic conditions in an urban health center

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Insurance status and access to urgent ambulatory care follow-up appointments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Access to emergency care: restricted by long waiting times and cost and coverage concerns

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Underlying causes of recurrent pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

The role of respiratory viruses in the origin and exacerbations of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Evaluation of recurrent pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Local guidelines for community-acquired pneumonia: development, implementation, and outcome studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Association of asthma control with health care utilization: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Role of the specialist in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Clinical practice guidelines vs actual clinical practice : the asthma paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Recent trends in asthma hospitalization and mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960638-2

7 January 2021

10.1016/S1081-1206(10)60638-2

Identifiers

DOI

1 reference

14 September 2017

1 reference